4.3 Article

The Comparative Bioavailability of Fluticasone and Azelastine Delivered as a Single Fixed Dose Combination (MP-AzeFlu) in Comparison to Two Different Formulations of Azelastine and Fluticasone Propionate Following Intranasal Administration in Healthy Chinese Volunteers

Related references

Note: Only part of the references are listed.
Article Chemistry, Medicinal

Pharmacokinetics and Bioequivalence Evaluation of Two Montelukast Sodium Chewable Tablets in Healthy Chinese Volunteers Under Fasted and Fed Conditions

Weihong Li et al.

Summary: The study aimed to compare the pharmacokinetic properties and bioequivalence of montelukast sodium chewable tablets from two manufacturers in Chinese volunteers. The results showed that the two formulations were bioequivalent and had similar safety profiles in healthy Chinese subjects.

DRUG DESIGN DEVELOPMENT AND THERAPY (2021)

Article Allergy

Onset of Action of the Fixed Combination Intranasal Azelastine-Fluticasone Propionate in an Allergen Exposure Chamber

Jean Bousquet et al.

JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY-IN PRACTICE (2018)

Article Pharmacology & Pharmacy

Bioavailability and disposition of azelastine and fluticasone propionate when delivered by MP29-02, a novel aqueous nasal spray

Hartmut Derendorf et al.

BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2012)

Review Pharmacology & Pharmacy

Salmeterol/Fluticasone Propionate A Review of its Use in Asthma

Kate McKeage et al.

DRUGS (2009)